A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 353 participants.
Also called NCT01252056
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 353 participants
- Registry
-
NCT01252056
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01252056. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2012-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy
- Condition
- Diabetic Nephropathy
- Intervention (Drug)
- Probucol
- Intervention (Drug)
- Probucol and Cilostazol
- Lead sponsor
- Otsuka Beijing Research Institute
Record details
- Record id
cardio:ct-nct01252056- Content hash
9db5237f971255fc8fad4a59654ee35a138ddea0bf364ed3475624386d631797